WO2007067482A3 - Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate - Google Patents

Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate Download PDF

Info

Publication number
WO2007067482A3
WO2007067482A3 PCT/US2006/046246 US2006046246W WO2007067482A3 WO 2007067482 A3 WO2007067482 A3 WO 2007067482A3 US 2006046246 W US2006046246 W US 2006046246W WO 2007067482 A3 WO2007067482 A3 WO 2007067482A3
Authority
WO
WIPO (PCT)
Prior art keywords
blood
acetate
treatment
storage
endogenous
Prior art date
Application number
PCT/US2006/046246
Other languages
French (fr)
Other versions
WO2007067482A2 (en
Inventor
Raymond P Goodrich
Junzhi Li
Original Assignee
Navigant Biotechnologies Llc
Raymond P Goodrich
Junzhi Li
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Navigant Biotechnologies Llc, Raymond P Goodrich, Junzhi Li filed Critical Navigant Biotechnologies Llc
Priority to CA002629340A priority Critical patent/CA2629340A1/en
Priority to BRPI0618815-0A priority patent/BRPI0618815A2/en
Priority to EP06838930A priority patent/EP1956897A2/en
Priority to AU2006322038A priority patent/AU2006322038A1/en
Priority to JP2008544416A priority patent/JP2009518403A/en
Publication of WO2007067482A2 publication Critical patent/WO2007067482A2/en
Publication of WO2007067482A3 publication Critical patent/WO2007067482A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0215—Disinfecting agents, e.g. antimicrobials for preserving living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0278—Physical preservation processes
    • A01N1/0294—Electromagnetic, i.e. using electromagnetic radiation or electromagnetic fields
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electromagnetism (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Methods are provided for treatment and storage of blood and blood products using at least endogenous alloxazines and acetate. Methods include adding a blood component additive solution comprising at least an endogenous alloxazine and acetate to a fluid comprising at least one collected blood component.
PCT/US2006/046246 2005-12-06 2006-12-01 Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate WO2007067482A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA002629340A CA2629340A1 (en) 2005-12-06 2006-12-01 Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate
BRPI0618815-0A BRPI0618815A2 (en) 2005-12-06 2006-12-01 method for treating and storing blood and blood derivatives using endogenous alloxazine and acetate
EP06838930A EP1956897A2 (en) 2005-12-06 2006-12-01 Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate
AU2006322038A AU2006322038A1 (en) 2005-12-06 2006-12-01 Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate
JP2008544416A JP2009518403A (en) 2005-12-06 2006-12-01 Method for processing and storing blood and blood products using endogenous alloxazine and acetate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59750605P 2005-12-06 2005-12-06
US60/597,506 2005-12-06

Publications (2)

Publication Number Publication Date
WO2007067482A2 WO2007067482A2 (en) 2007-06-14
WO2007067482A3 true WO2007067482A3 (en) 2009-02-26

Family

ID=38007228

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/046246 WO2007067482A2 (en) 2005-12-06 2006-12-01 Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate

Country Status (8)

Country Link
EP (1) EP1956897A2 (en)
JP (1) JP2009518403A (en)
KR (1) KR20080084924A (en)
CN (1) CN101505591A (en)
AU (1) AU2006322038A1 (en)
BR (1) BRPI0618815A2 (en)
CA (1) CA2629340A1 (en)
WO (1) WO2007067482A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8835104B2 (en) 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
WO2012139017A1 (en) 2011-04-07 2012-10-11 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234808A (en) * 1991-10-30 1993-08-10 Thomas Jefferson University Acetate addition to platelets stored in plasma
US5344752A (en) * 1991-10-30 1994-09-06 Thomas Jefferson University Plasma-based platelet concentrate preparations
US5376524A (en) * 1991-04-01 1994-12-27 Thomas Jefferson University Platelet storage medium containing acetate and phosphate
WO2001094349A1 (en) * 2000-06-02 2001-12-13 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
WO2001096340A1 (en) * 2000-06-15 2001-12-20 Gambro, Inc. Method for inactivation of microorganisms using photosensitizers
WO2002043485A1 (en) * 2000-11-28 2002-06-06 Gambro, Inc. Storage solution containing photosensitizer for inactivation of biological contaminants
WO2003094979A1 (en) * 2002-05-06 2003-11-20 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376524A (en) * 1991-04-01 1994-12-27 Thomas Jefferson University Platelet storage medium containing acetate and phosphate
US5234808A (en) * 1991-10-30 1993-08-10 Thomas Jefferson University Acetate addition to platelets stored in plasma
US5344752A (en) * 1991-10-30 1994-09-06 Thomas Jefferson University Plasma-based platelet concentrate preparations
WO2001094349A1 (en) * 2000-06-02 2001-12-13 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
WO2001096340A1 (en) * 2000-06-15 2001-12-20 Gambro, Inc. Method for inactivation of microorganisms using photosensitizers
WO2002043485A1 (en) * 2000-11-28 2002-06-06 Gambro, Inc. Storage solution containing photosensitizer for inactivation of biological contaminants
WO2003094979A1 (en) * 2002-05-06 2003-11-20 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer

Also Published As

Publication number Publication date
BRPI0618815A2 (en) 2011-09-13
JP2009518403A (en) 2009-05-07
CN101505591A (en) 2009-08-12
KR20080084924A (en) 2008-09-22
WO2007067482A2 (en) 2007-06-14
CA2629340A1 (en) 2007-06-14
AU2006322038A1 (en) 2007-06-14
EP1956897A2 (en) 2008-08-20

Similar Documents

Publication Publication Date Title
WO2012047629A3 (en) Selective removal of age-modified cells for treatment of ather0sclerosis
WO2007129323A3 (en) Device and method for vascular filter
EP2709520A4 (en) Devices, systems, and methods for assessing implants, organs, transplants, tissues, synthetic constructs, vascular grafts, and the like
WO2007101225A3 (en) Methods to identify inhibitors of the unfolded protein response
PT2324871T (en) Citrate anticoagulation system for extracorporeal blood treatments
WO2012003377A3 (en) Methods of preparing chorion tissue and products derived therefrom
EP2101761A4 (en) Methods for preserving renal function using xanthine oxidoreductase inhibitors
ATE485264T1 (en) PROLYL HYDROXYLASE INHIBITORS AND METHOD FOR USE THEREOF
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
WO2010120757A3 (en) Regeneration of tissue without cell transplantation
WO2010091049A3 (en) Diagnosis and treatment of cancer
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
WO2011138450A3 (en) Foaming cosmetic composition containing ellagic acid or one of the salts thereof and an essential oil
WO2009146913A3 (en) Organizer for the releasable accommodation of components of blood line sets and method for producing and preparing the same
EP1874922A4 (en) Method of using stroma cells from cord blood to expand and engraft nucleated cells from cord blood
WO2009149258A3 (en) Crystalline form of 6-[(4s)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
WO2006057674A3 (en) COMPOSITIONS AND METHODS FOR EX VIVO PRESERVATION OF BLOOD VESSELS FOR VASCULAR GRAFTS USING ANALOGUES OF cAMP AND cGMP
MX2010006650A (en) Materials and methods for treatment of pathological ocular vascular proliferation.
WO2012037299A3 (en) Fatty acid synthase inhibitors
WO2007067482A3 (en) Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate
WO2008099469A1 (en) Composition and method for suppressing lipid peroxidation in erythrocytes
WO2007049089A8 (en) Method of stimulating growth of functional blood vessels and/or regeneration of myocardium in damaged tissues
WO2009109574A3 (en) Methods for the anti-inflammatory and anti-edematous protection of explanted biological material until the transplantation thereof in patients
EP2104469A4 (en) Method and device for preserving the vitality and function of a harvested blood vessel
WO2010030082A3 (en) Mastic extract, and method for extracting same

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680045661.X

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006838930

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006322038

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2006322038

Country of ref document: AU

Date of ref document: 20061201

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2629340

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1020087011902

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2008544416

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: PI0618815

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080520